Literature DB >> 33841691

The clinical value of color Doppler ultrasonography in measuring the hemodynamics of liver cirrhosis patients' portal and splenic veins.

Ran Hui1, Zhe Li1, Zongjie Liu1, Xiuping Liu2, Heping Deng1.   

Abstract

OBJECTIVE: To investigate the clinical value of color Doppler ultrasonography (CDUS) in measuring the hemodynamics of liver cirrhosis (LC) patients' portal and splenic veins.
METHODS: The clinical data of 81 LC patients admitted to our hospital were collected retrospectively and classified into Group A, and the clinical data from 51 healthy volunteers were classified into Group B. All the patients were examined with CDUS, and the ultrasonography images were analyzed. The hemodynamic indices of the portal and splenic veins were compared, and the differences in the hemodynamic indices of the LC patients with varying degrees of esophageal varices and hepatic injuries were analyzed.
RESULTS: Group A exhibited higher Qpv, Dpv, Qsv, and Dsv and lower Vpv and Vsv than Group B (P < 0.05). The Qpv and Dpv of the patients with Grade B LC were higher than they were in the patients with Grade A LC and lower than they were in the patients with Grade C LC (P < 0.05). The Vpv of the patients with Grade B LC was higher than it was in the patients with Grade C LC and lower than it was in the patients with Grade A LC (P < 0.05). The Qsv and Dsv of the patients with Grade B LC were higher than they were in the patients with Grade A LC and lower than they were in the patients with Grade C LC (P < 0.05). The Vsv of the patients with Grade B LC was higher than it was in the patients with Grade C LC and lower than it was in the patients with Grade A LC (P < 0.05). The patients with mild, moderate, and severe esophageal varices showed lower Vpv and Vsv and higher Qpv, Dpv, Qsv, and Dsv than the patients without esophageal varices (P < 0.05).
CONCLUSION: CDUS has certain clinical values in measuring the hemodynamics of LC patients' portal and splenic veins and can be used to predict the degrees of hepatic injuries and esophageal varices. AJTR
Copyright © 2021.

Entities:  

Keywords:  Liver cirrhosis; clinical value; color Doppler ultrasonography; hemodynamics; portal vein; splenic vein

Year:  2021        PMID: 33841691      PMCID: PMC8014353     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  24 in total

1.  Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.

Authors:  Michel Bergère; Domitille Erard-Poinsot; Olivier Boillot; Pierre-Jean Valette; Olivier Guillaud; Christine Chambon-Augoyard; Jérôme Dumortier
Journal:  Clin Res Hepatol Gastroenterol       Date:  2018-12-18       Impact factor: 2.947

2.  Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.

Authors:  Susana G Rodrigues; Sebastian Sixt; Juan G Abraldes; Andrea De Gottardi; Christoph Klinger; Jaime Bosch; Iris Baumgartner; Annalisa Berzigotti
Journal:  Aliment Pharmacol Ther       Date:  2018-11-18       Impact factor: 8.171

Review 3.  Cirrhosis and Portal Hypertension in the Pediatric Population.

Authors:  Catherine A Chapin; Lee M Bass
Journal:  Clin Liver Dis       Date:  2018-08-22       Impact factor: 6.126

Review 4.  Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.

Authors:  Nicolas M Intagliata; Stephen H Caldwell; Armando Tripodi
Journal:  Gastroenterology       Date:  2019-02-13       Impact factor: 22.682

5.  Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.

Authors:  M Yu Nadinskaia; Kh B Kodzoeva; K A Ulyanova; A S Volkova; S I Rogacheva; A S Dekhanov; D A Strelkova; V T Ivashkin
Journal:  Ter Arkh       Date:  2019-03-18       Impact factor: 0.467

6.  Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.

Authors:  Bartley Thornburg; Kush Desai; Ryan Hickey; Elias Hohlastos; Laura Kulik; Daniel Ganger; Talia Baker; Michael Abecassis; Juan C Caicedo; Daniela Ladner; Jonathan Fryer; Ahsun Riaz; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2017-10-17       Impact factor: 3.464

7.  Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.

Authors:  Lydia Giannitrapani; Walter Granà; Anna Licata; Cosima Schiavone; Giuseppe Montalto; Maurizio Soresi
Journal:  Med Princ Pract       Date:  2018-08-14       Impact factor: 1.927

8.  Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.

Authors:  Bernhard Scheiner; Paul René Stammet; Sebastian Pokorny; Theresa Bucsics; Philipp Schwabl; Andrea Brichta; Johannes Thaler; Katharina Lampichler; Ahmed Ba-Ssalamah; Cihan Ay; Arnulf Ferlitsch; Michael Trauner; Mattias Mandorfer; Thomas Reiberger
Journal:  Wien Klin Wochenschr       Date:  2018-06-18       Impact factor: 1.704

9.  Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.

Authors:  Jian Wang; Jia-Sui Chai; Ya-Min Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 10.  Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.

Authors:  Mariella Faccia; Maria Elena Ainora; Francesca Romana Ponziani; Laura Riccardi; Matteo Garcovich; Antonio Gasbarrini; Maurizio Pompili; Maria Assunta Zocco
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

View more
  1 in total

1.  Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver.

Authors:  Peiwan Jia; Ruirong Liu; Yun Liu; Yanyan Wu; Ting Dou
Journal:  Contrast Media Mol Imaging       Date:  2022-02-02       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.